Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 3Withdrawn 2Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Postgastrectomy Syndromes 1Pancreatic Neoplasms 1

Interventions

Fluorouracil 51Oxaliplatin 49Gemcitabine 47Leucovorin 41Capecitabine 35Bevacizumab 29Irinotecan 25Cisplatin 22Radiotherapy 18Radiosurgery 18pembrolizumab 16Nivolumab 16Cetuximab 15Taxes 14Sorafenib 14Paclitaxel 13Biopsy 13Surgical Procedures, Operative 12Drug Therapy 11atezolizumab 10Radiation 10Albumin-Bound Paclitaxel 10lenvatinib 9durvalumab 9Magnetic Resonance Spectroscopy 9Folfox protocol 9Cyclophosphamide 9130-nm albumin-bound paclitaxel 9spartalizumab 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gastroenterostomy × Gastrointestinal × Clear all
NCT01569282 2019-03-22

Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer

Göteborg University

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00622804 2009-08-03

Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy

The Catholic University of Korea

Phase 3 Withdrawn
90 enrolled
Gastrointestinal

Postgastrectomy Syndromes, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡